Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-10

Clinical Trial Update: Antineoplaston Therapy in Treating Children With Primitive Neuroectodermal Tumors [Phase 2]

View source ↗

Summary

A phase 2 clinical trial tested antineoplaston therapy for childhood central nervous system primitive neuroectodermal tumors. The study is completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Childhood CNS Primitive Neuroectodermal Tumor | Phase 2 | Status: COMPLETED | Results posted: 2016-11-10